| activation of protein kinase activity |
Any process that initiates the activity of an inactive protein kinase. |
| aging |
A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700). |
| angiogenesis |
Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels. |
| angiogenesis involved in coronary vascular morphogenesis |
Blood vessel formation in the heart when new vessels emerge from the proliferation of pre-existing blood vessels. |
| apoptotic process |
A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died. |
| artery morphogenesis |
The process in which the anatomical structures of arterial blood vessels are generated and organized. Arteries are blood vessels that transport blood from the heart to the body and its organs. |
| blood vessel development |
The process whose specific outcome is the progression of a blood vessel over time, from its formation to the mature structure. The blood vessel is the vasculature carrying blood. |
| blood vessel morphogenesis |
The process in which the anatomical structures of blood vessels are generated and organized. The blood vessel is the vasculature carrying blood. |
| blood vessel remodeling |
The reorganization or renovation of existing blood vessels. |
| bone trabecula formation |
The process of creating a trabecula in the bone. A trabecula is a tissue element in the form of a small beam, strut or rod. |
| bone trabecula morphogenesis |
The process of shaping a trabecula in bone. A trabecula is a tissue element in the form of a small beam, strut or rod. |
| branching involved in blood vessel morphogenesis |
The process of coordinated growth and sprouting of blood vessels giving rise to the organized vascular system. |
| camera-type eye morphogenesis |
The process in which the anatomical structures of the eye are generated and organized. The camera-type eye is an organ of sight that receives light through an aperture and focuses it through a lens, projecting it on a photoreceptor field. |
| cardiac muscle cell development |
The process whose specific outcome is the progression of a cardiac muscle cell over time, from its formation to the mature state. |
| cardiac vascular smooth muscle cell development |
The process whose specific outcome is the progression of a cardiac vascular smooth muscle cell over time, from its formation to the mature state. |
| cell chemotaxis |
The directed movement of a motile cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis). |
| cell maturation |
A developmental process, independent of morphogenetic (shape) change, that is required for a cell to attain its fully functional state. |
| cell migration |
The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms. |
| cell migration involved in sprouting angiogenesis |
The orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels involved in sprouting angiogenesis. |
| cell population proliferation |
The multiplication or reproduction of cells, resulting in the expansion of a cell population. |
| cell-cell adhesion |
The attachment of one cell to another cell via adhesion molecules. |
| cellular response to dexamethasone stimulus |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a dexamethasone stimulus. |
| cellular response to fibroblast growth factor stimulus |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an fibroblast growth factor stimulus. |
| cellular response to hypoxia |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level. |
| cellular response to mechanical stimulus |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus. |
| cellular response to vascular endothelial growth factor stimulus |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vascular endothelial growth factor stimulus. |
| cellular response to xenobiotic stimulus |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a xenobiotic, a compound foreign to the organism exposed to it. It may be synthesized by another organism (like ampicilin) or it can be a synthetic chemical. |
| cellular stress response to acid chemical |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a disturbance in cellular homeostasis caused by the chemical structure of the anion portion of a dissociated acid (rather than the acid acting as a proton donor). The acid chemical may be in gaseous, liquid or solid form. |
| commissural neuron axon guidance |
The process in which the migration of an axon growth cone of a commissural neuron is directed to its target in the brain in response to a combination of attractive and repulsive cues. |
| coronary artery morphogenesis |
The process in which the anatomical structures of coronary arteries are generated and organized. Coronary arteries are blood vessels that transport blood to the heart muscle. |
| coronary vein morphogenesis |
The process in which the anatomical structures of veins of the heart are generated and organized. |
| dopaminergic neuron differentiation |
The process in which a neuroblast acquires the specialized structural and functional features of a dopaminergic neuron, a neuron that secretes dopamine. |
| endothelial cell chemotaxis |
The directed movement of an endothelial cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis). |
| endothelial cell migration |
The orderly movement of an endothelial cell into the extracellular matrix to form an endothelium. |
| endothelial cell proliferation |
The multiplication or reproduction of endothelial cells, resulting in the expansion of a cell population. Endothelial cells are thin flattened cells which line the inside surfaces of body cavities, blood vessels, and lymph vessels, making up the endothelium. |
| epithelial cell differentiation |
The process in which a relatively unspecialized cell acquires specialized features of an epithelial cell, any of the cells making up an epithelium. |
| epithelial cell maturation |
The developmental process, independent of morphogenetic (shape) change, that is required for an epithelial cell to attain its fully functional state. An epithelial cell is a cell usually found in a two-dimensional sheet with a free surface. |
| epithelial cell proliferation |
The multiplication or reproduction of epithelial cells, resulting in the expansion of a cell population. Epithelial cells make up the epithelium, the covering of internal and external surfaces of the body, including the lining of vessels and other small cavities. It consists of cells joined by small amounts of cementing substances. |
| eye photoreceptor cell development |
Development of a photoreceptor, a sensory cell in the eye that reacts to the presence of light. They usually contain a pigment that undergoes a chemical change when light is absorbed, thus stimulating a nerve. |
| female pregnancy |
The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth. |
| heart morphogenesis |
The developmental process in which the heart is generated and organized. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood. |
| homeostasis of number of cells within a tissue |
Any biological process involved in the maintenance of the steady-state number of cells within a population of cells in a tissue. |
| in utero embryonic development |
The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus. |
| induction of positive chemotaxis |
Any process that initiates the directed movement of a motile cell or organism towards a higher concentration in a concentration gradient of a specific chemical. |
| kidney development |
The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine. |
| lactation |
The regulated release of milk from the mammary glands and the period of time that a mother lactates to feed her young. |
| lung alveolus development |
The process whose specific outcome is the progression of the alveolus over time, from its formation to the mature structure. The alveolus is a sac for holding air in the lungs; formed by the terminal dilation of air passageways. |
| lung development |
The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax. |
| lung vasculature development |
The biological process whose specific outcome is the progression of a lung vasculature from an initial condition to its mature state. This process begins with the formation of the lung vasculature and ends with the mature structure. The lung vasculature is composed of the tubule structures that carry blood or lymph in the lungs. |
| lymph vessel morphogenesis |
The process in which the anatomical structures of lymph vessels are generated and organized. The lymph vessel is the vasculature carrying lymph. |
| lymphangiogenesis |
Lymph vessel formation when new vessels emerge from the proliferation of pre-existing vessels. |
| macrophage differentiation |
The process in which a relatively unspecialized monocyte acquires the specialized features of a macrophage. |
| mammary gland alveolus development |
The progression of the mammary gland alveolus over time, from its formation to its mature state. The mammary gland alveolus is a sac-like structure that is found in the mature gland. |
| mesoderm development |
The process whose specific outcome is the progression of the mesoderm over time, from its formation to the mature structure. The mesoderm is the middle germ layer that develops into muscle, bone, cartilage, blood and connective tissue. |
| monocyte differentiation |
The process in which a relatively unspecialized myeloid precursor cell acquires the specialized features of a monocyte. |
| motor neuron migration |
The orderly movement of a motor neuron from one site to another. A motor neuron is an efferent neuron that passes from the central nervous system or a ganglion toward or to a muscle and conducts an impulse that causes movement. |
| mRNA stabilization |
Prevention of degradation of mRNA molecules. In the absence of compensating changes in other processes, the slowing of mRNA degradation can result in an overall increase in the population of active mRNA molecules. |
| negative regulation of adherens junction organization |
Any process that stops, prevents or reduces the frequency, rate or extent of adherens junction organization. |
| negative regulation of apoptotic process |
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. |
| negative regulation of blood-brain barrier permeability |
Any process that decreases blood-brain barrier permeability, the quality of the blood-brain barrier that allows for a controlled passage of substances (e.g. macromolecules, small molecules, ions) into and out of the brain. |
| negative regulation of bone resorption |
Any process that stops, prevents, or reduces the frequency, rate or extent of bone resorption. |
| negative regulation of cell-cell adhesion |
Any process that stops, prevents or reduces the rate or extent of cell adhesion to another cell. |
| negative regulation of cell-cell adhesion mediated by cadherin |
Any process that stops, prevents, or reduces the frequency, rate or extent of cell-cell adhesion mediated by cadherin. |
| negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
Any process that stops, prevents, or reduces the frequency, rate or extent of a cysteine-type endopeptidase activity involved in the apoptotic process. |
| negative regulation of epithelial to mesenchymal transition |
Any process that decreases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell. |
| negative regulation of establishment of endothelial barrier |
Any process that stops, prevents or reduces the frequency, rate or extent of establishment of endothelial barrier. |
| negative regulation of fat cell differentiation |
Any process that stops, prevents, or reduces the frequency, rate or extent of adipocyte differentiation. |
| negative regulation of gene expression |
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA). |
| negative regulation of neuron death |
Any process that stops, prevents or reduces the frequency, rate or extent of neuron death. |
| negative regulation of programmed cell death |
Any process that stops, prevents, or reduces the frequency, rate or extent of programmed cell death, cell death resulting from activation of endogenous cellular processes. |
| negative regulation of transcription by RNA polymerase II |
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II. |
| nervous system development |
The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state. |
| neuroblast proliferation |
The expansion of a neuroblast population by cell division. A neuroblast is any cell that will divide and give rise to a neuron. |
| outflow tract morphogenesis |
The process in which the anatomical structures of the outflow tract are generated and organized. The outflow tract is the portion of the heart through which blood flows into the arteries. |
| ovarian follicle development |
The process whose specific outcome is the progression of the ovarian follicle over time, from its formation to the mature structure. |
| peptidyl-tyrosine phosphorylation |
The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine. |
| positive chemotaxis |
The directed movement of a motile cell or organism towards a higher concentration of a chemical. |
| positive regulation of angiogenesis |
Any process that activates or increases angiogenesis. |
| positive regulation of axon extension involved in axon guidance |
Any process that activates, maintains or increases the frequency, rate or extent of axon extension involved in axon guidance. |
| positive regulation of blood vessel endothelial cell migration |
Any process that activates or increases the frequency, rate or extent of the migration of the endothelial cells of blood vessels. |
| positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
Any process that activates or increases the frequency, rate or extent of blood vessel endothelial cell proliferation involved in sprouting angiogenesis. |
| positive regulation of branching involved in ureteric bud morphogenesis |
Any process that increases the rate, frequency or extent of branching involved in ureteric bud morphogenesis, the process in which the branching structure of the ureteric bud is generated and organized. The ureteric bud is an epithelial tube that grows out from the metanephric duct. The bud elongates and branches to give rise to the ureter and kidney collecting tubules. |
| positive regulation of cell adhesion |
Any process that activates or increases the frequency, rate or extent of cell adhesion. |
| positive regulation of cell division |
Any process that activates or increases the frequency, rate or extent of cell division. |
| positive regulation of cell migration |
Any process that activates or increases the frequency, rate or extent of cell migration. |
| positive regulation of cell migration involved in sprouting angiogenesis |
Any process that increases the frequency, rate or extent of cell migration involved in sprouting angiogenesis. Cell migration involved in sprouting angiogenesis is the orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels contributing to the process of sprouting angiogenesis. |
| positive regulation of cell population proliferation |
Any process that activates or increases the rate or extent of cell proliferation. |
| positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway |
The series of molecular signals initiated by vascular endothelial growth factor (VEGF) binding to a platelet-derived growth factor receptor (PDGFR) on the surface of a cell, which activates or increases the frequency, rate or extent of cell proliferation. |
| positive regulation of cold-induced thermogenesis |
Any process that activates or increases the frequency, rate or extent of cold-induced thermogenesis. |
| positive regulation of CREB transcription factor activity |
Any process that activates or increases the frequency, rate or extent of activity of the transcription factor CREB. |
| positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway |
The series of molecular signals initiated by the binding of a vascular endothelial growth factor (VEGF) to its receptor on the surface of a cell, which activates or increases the frequency, rate or extent of endothelial cell chemotaxis. |
| positive regulation of endothelial cell migration |
Any process that increases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium. |
| positive regulation of endothelial cell proliferation |
Any process that activates or increases the rate or extent of endothelial cell proliferation. |
| positive regulation of epithelial cell proliferation |
Any process that activates or increases the rate or extent of epithelial cell proliferation. |
| positive regulation of focal adhesion assembly |
Any process that activates or increases the frequency, rate or extent of focal adhesion assembly, the establishment and maturation of focal adhesions. |
| positive regulation of gene expression |
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA). |
| positive regulation of histone deacetylase activity |
Any process that activates or increases the frequency, rate or extent of histone deacetylase activity. |
| positive regulation of lymphangiogenesis |
Any process that activates or increases the frequency, rate or extent of lymphangiogenesis. |
| positive regulation of MAP kinase activity |
Any process that activates or increases the frequency, rate or extent of MAP kinase activity. |
| positive regulation of mast cell chemotaxis |
Any process that increases the rate, frequency or extent of mast cell chemotaxis. Mast cell chemotaxis is the movement of a mast cell in response to an external stimulus. |
| positive regulation of neuroblast proliferation |
Any process that activates or increases the rate of neuroblast proliferation. |
| positive regulation of osteoblast differentiation |
Any process that activates or increases the frequency, rate or extent of osteoblast differentiation. |
| positive regulation of p38MAPK cascade |
Any process that activates or increases the frequency, rate or extent of p38MAPK cascade. |
| positive regulation of peptidyl-serine phosphorylation |
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine. |
| positive regulation of peptidyl-tyrosine autophosphorylation |
Any process that activates or increases the frequency, rate or extent of peptidyl-tyrosine autophosphorylation. |
| positive regulation of peptidyl-tyrosine phosphorylation |
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine. |
| positive regulation of phosphatidylinositol 3-kinase signaling |
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade. |
| positive regulation of phosphorylation |
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to a molecule. |
| positive regulation of positive chemotaxis |
Any process that activates or increases the frequency, rate or extent of the directed movement of a motile cell or organism towards a higher concentration in a concentration gradient of a specific chemical. |
| positive regulation of protein autophosphorylation |
Any process that activates or increases the frequency, rate or extent of the phosphorylation by a protein of one or more of its own residues. |
| positive regulation of protein kinase B signaling |
Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B. |
| positive regulation of protein kinase C signaling |
Any process that increases the frequency, rate, or extent of a series of reactions, mediated by the intracellular serine/threonine kinase protein kinase C, which occurs as a result of a single trigger reaction or compound. |
| positive regulation of protein kinase D signaling |
Any process that activates or increases the frequency, rate or extent of protein kinase D signaling. |
| positive regulation of protein phosphorylation |
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein. |
| positive regulation of protein-containing complex assembly |
Any process that activates or increases the frequency, rate or extent of protein complex assembly. |
| positive regulation of receptor internalization |
Any process that activates or increases the frequency, rate or extent of receptor internalization. |
| positive regulation of retinal ganglion cell axon guidance |
Any process that activates or increases the frequency, rate or extent of retinal ganglion cell axon guidance. |
| positive regulation of signal transduction |
Any process that activates or increases the frequency, rate or extent of signal transduction. |
| positive regulation of smooth muscle cell proliferation |
Any process that activates or increases the rate or extent of smooth muscle cell proliferation. |
| positive regulation of sprouting angiogenesis |
Any process that activates or increases the frequency, rate or extent of sprouting angiogenesis. |
| positive regulation of transcription by RNA polymerase II |
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
| positive regulation of transcription from RNA polymerase II promoter in response to hypoxia |
Any process that increases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a hypoxia stimulus. |
| positive regulation of trophoblast cell migration |
Any process that activates or increases the frequency, rate or extent of trophoblast cell migration. |
| positive regulation of vascular permeability |
Any process that increases the extent to which blood vessels can be pervaded by fluid. |
| post-embryonic camera-type eye development |
The process occurring during the post-embryonic phase whose specific outcome is the progression of the camera-type eye over time, from its formation to the mature structure. |
| primitive erythrocyte differentiation |
Erythrocyte differentiation which occurs as part of the process of primitive hemopoiesis. |
| regulation of cell shape |
Any process that modulates the surface configuration of a cell. |
| regulation of endothelial cell differentiation |
Any process that modulates the frequency, rate or extent of endothelial cell differentiation. |
| regulation of growth |
Any process that modulates the frequency, rate or extent of the growth of all or part of an organism so that it occurs at its proper speed, either globally or in a specific part of the organism's development. |
| regulation of hematopoietic progenitor cell differentiation |
Any process that modulates the frequency, rate or extent of hematopoietic progenitor cell differentiation. |
| regulation of nitric oxide mediated signal transduction |
Any process that modulates the rate, frequency or extent of nitric oxide mediated signal transduction. Nitric oxide mediated signal transduction is The series of molecular signals mediated by the detection of nitric oxide (NO). |
| regulation of retinal ganglion cell axon guidance |
Any process that modulates the frequency, rate, or extent of retinal ganglion cell axon guidance, the process in which the migration of an axon growth cone of a retinal ganglion cell (RGC) is directed to its target in the brain in response to a combination of attractive and repulsive cues. |
| response to cold |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cold stimulus, a temperature stimulus below the optimal temperature for that organism. |
| response to dexamethasone |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a dexamethasone stimulus. |
| response to estradiol |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen. |
| response to folic acid |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a folic acid stimulus. |
| response to hypoxia |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level. |
| response to oxygen levels |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting the presence, absence, or concentration of oxygen. |
| response to progesterone |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a progesterone stimulus. |
| response to vitamin A |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin A stimulus. |
| sprouting angiogenesis |
The extension of new blood vessels from existing vessels into avascular tissues, this process includes the specialization of endothelial cells into leading tip and stalk cells, proliferation and migration of the endothelial cells and cell adhesion resulting in angiogenic sprout fusion or lumen formation. |
| surfactant homeostasis |
Any process involved in the maintenance of a steady-state level of the surface-active lipoprotein mixture which coats the alveoli. |
| T-helper 1 type immune response |
An immune response which is associated with resistance to intracellular bacteria, fungi, and protozoa, and pathological conditions such as arthritis, and which is typically orchestrated by the production of particular cytokines by T-helper 1 cells, most notably interferon-gamma, IL-2, and lymphotoxin. |
| tube formation |
Creation of the central hole of a tube in an anatomical structure through which gases and/or liquids flow. |
| vascular endothelial growth factor receptor signaling pathway |
The series of molecular signals initiated by a ligand binding to a vascular endothelial growth factor receptor (VEGFR) on the surface of the target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. |
| vascular endothelial growth factor receptor-2 signaling pathway |
The series of molecular signals initiated by a ligand binding to a vascular endothelial growth factor receptor-2 (VEGFR-2) on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. |
| vascular endothelial growth factor signaling pathway |
The series of molecular signals initiated by vascular endothelial growth factor (VEGF) binding its receptor on the surface of the target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. |
| vascular wound healing |
Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels and contribute to the series of events that restore integrity to damaged vasculature. |
| vasculature development |
The process whose specific outcome is the progression of the vasculature over time, from its formation to the mature structure. The vasculature is an interconnected tubular multi-tissue structure that contains fluid that is actively transported around the organism. |
| vasodilation |
An increase in the internal diameter of blood vessels, especially arterioles or capillaries, due to relaxation of smooth muscle cells that line the vessels, and usually resulting in a decrease in blood pressure. |
| VEGF-activated neuropilin signaling pathway |
The series of molecular signals initiated by vascular endothelial growth factor (VEGF) binding to a neuropilin protein on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. |
| wound healing |
The series of events that restore integrity to a damaged tissue, following an injury. |